AdaptHealth (AHCO) Cash & Current Investments (2017 - 2026)
AdaptHealth (AHCO) posted quarterly Cash & Current Investments of $48.0 million for Q1 2026, down 10.6% year-over-year from $53.6 million in Q1 2025, and down 54.81% quarter-over-quarter from $106.1 million in Q4 2025.
AdaptHealth (AHCO) Cash & Current Investments (2017 - 2026) Analysis & Trends
AdaptHealth's Cash & Current Investments history runs 10 years deep, the most recent figure standing at $48.0 million for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 10.6% year-over-year to $48.0 million; the TTM figure through Mar 2026 stood at $48.0 million (down 10.6% YoY), while the FY2025 annual figure was $106.1 million, down 3.29% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $48.0 million, down from $106.1 million in the prior quarter.
- The five-year high for Cash & Current Investments was $119.4 million in Q1 2022, with the low at $45.1 million in Q2 2023.
- The 5-year median for Cash & Current Investments is $79.6 million (2024), against an average of $81.8 million.
- The sharpest annual moves came in 2022 and 2024: Cash & Current Investments slumped 69.08% in 2022, then surged 78.44% in 2024.
- AdaptHealth's Cash & Current Investments stood at $46.3 million in 2022, then soared by 66.69% to $77.1 million in 2023, then jumped by 42.28% to $109.7 million in 2024, then slipped by 3.29% to $106.1 million in 2025, then sank by 54.81% to $48.0 million in 2026.
- Business Quant data shows AHCO's Cash & Current Investments at $48.0 million in Q1 2026, $106.1 million in Q4 2025, and $80.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | AdaptHealth | 730.28 Mn | 686.99 Mn | 104.21 Mn | 43.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.29 Mn |
| Mar 31, 2026 | 47.96 Mn |
| Dec 31, 2025 | 106.14 Mn |
| Sep 30, 2025 | 80.36 Mn |
| Jun 30, 2025 | 68.63 Mn |
| Mar 31, 2025 | 53.65 Mn |
| Dec 31, 2024 | 109.75 Mn |
| Sep 30, 2024 | 100.18 Mn |
| Jun 30, 2024 | 69.83 Mn |
| Mar 31, 2024 | 79.57 Mn |
| Dec 31, 2023 | 77.13 Mn |
| Sep 30, 2023 | 56.14 Mn |
| Jun 30, 2023 | 45.13 Mn |
| Mar 31, 2023 | 101.40 Mn |
| Dec 31, 2022 | 46.27 Mn |
| Sep 30, 2022 | 110.74 Mn |
| Jun 30, 2022 | 118.81 Mn |
| Mar 31, 2022 | 119.43 Mn |
| Dec 31, 2021 | 149.63 Mn |
| Sep 30, 2021 | 336.65 Mn |